Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 1 | 647 | 1q42.13 | COQ8A | coenzyme Q8A | |
Mouse | 1 | 645 | 1 H4 | Coq8a | coenzyme Q8A | |
Rat | 1 | 649 | 13q26 | Coq8a | coenzyme Q8A |
Previous and Unofficial Names |
CABC1 | chaperone activity of bc1 complex-like, mitochondrial | chaperone, ABC1 activity of bc1 complex homolog | SCAR9 | ADCK3 |
Database Links | |
Alphafold | Q8NI60 (Hs), Q60936 (Mm), Q5BJQ0 (Rn) |
BRENDA | 2.7.11.- |
ChEMBL Target | CHEMBL5550 (Hs) |
Ensembl Gene | ENSG00000163050 (Hs), ENSMUSG00000026489 (Mm), ENSRNOG00000043201 (Rn) |
Entrez Gene | 56997 (Hs), 67426 (Mm), 360887 (Rn) |
Human Protein Atlas | ENSG00000163050 (Hs) |
KEGG Enzyme | 2.7.11.- |
KEGG Gene | hsa:56997 (Hs), mmu:67426 (Mm), rno:360887 (Rn) |
OMIM | 606980 (Hs) |
Orphanet | ORPHA140053 (Hs) |
Pharos | Q8NI60 (Hs) |
RefSeq Nucleotide | NM_020247 (Hs), NM_001163290 (Mm), NM_001013185 (Rn) |
RefSeq Protein | NP_064632 (Hs), NP_001156762 (Mm), NP_001013203 (Rn) |
UniProtKB | Q8NI60 (Hs), Q60936 (Mm), Q5BJQ0 (Rn) |
Wikipedia | COQ8A (Hs) |
Enzyme Reaction | ||||
|
DiscoveRx KINOMEscan® screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1-2 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: ADCK3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||||
|
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
ABC1-B subfamily: coenzyme Q8A. Last modified on 18/08/2014. Accessed on 11/12/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=1927.